These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25532458)

  • 1. Computer-aided molecular pathology interpretation in exploring prospective markers for oral submucous fibrosis progression.
    Anura A; Conjeti S; Das RK; Pal M; Paul RR; Bag S; Ray AK; Chatterjee J
    Head Neck; 2016 May; 38(5):653-69. PubMed ID: 25532458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
    Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
    Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
    Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
    J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study.
    Pammar C; Nayak RS; Kotrashetti VS; Hosmani J
    J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes.
    Anura A; Kazi A; Pal M; Paul RR; Sengupta S; Chatterjee J
    Histochem Cell Biol; 2018 Jul; 150(1):61-75. PubMed ID: 29687243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
    Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
    J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
    Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation.
    Costa AF; Tasso MG; Mariano FV; Soares AB; Chone CT; Crespo AN; Fresno MF; Llorente JL; Suárez C; de Araújo VC; Hermsen M; Altemani A
    Histopathology; 2012 Apr; 60(5):816-25. PubMed ID: 22320429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
    Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
    J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
    Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
    PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer.
    Bag S; Pal M; Chaudhary A; Das RK; Paul RR; Sengupta S; Chatterjee J
    J Clin Pathol; 2015 Aug; 68(8):605-13. PubMed ID: 26038241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
    Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enigmatic pathogenetic mechanism of hypoxia inducible factor - 1/2 alpha in the progression of fibrosis of oral submucous fibrosis and its malignant transformation: A systematic review and meta-analysis.
    R K; Chandra A; Jain T; Singh N; Agrawal R
    Arch Oral Biol; 2024 Jun; 162():105944. PubMed ID: 38492547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression.
    Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Sengupta S; Chatterjee J
    J Clin Pathol; 2010 Oct; 63(10):894-9. PubMed ID: 20876321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
    Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
    Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
    Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
    Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
    Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
    J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.